Literature DB >> 20482315

Structure, mechanism and inhibition of gamma-secretase and presenilin-like proteases.

Michael S Wolfe1.   

Abstract

Presenilin is the catalytic component of gamma-secretase, a complex aspartyl protease and a founding member of intramembrane-cleaving proteases. gamma-Secretase is involved in the pathogenesis of Alzheimer's disease and a top target for therapeutic intervention. However, the protease complex processes a variety of transmembrane substrates, including the Notch receptor, raising concerns about toxicity. Nevertheless, gamma-secretase inhibitors and modulators have been identified that allow Notch processing and signaling to continue, and promising compounds are entering clinical trials. Molecular and biochemical studies offer a model for how this protease hydrolyzes transmembrane domains in the confines of the lipid bilayer. Progress has also been made toward structure elucidation of presenilin and the gamma-secretase complex by electron microscopy as well as by studying cysteine-mutant presenilins. The signal peptide peptidase (SPP) family of proteases are distantly related to presenilins. However, the SPPs work as single polypeptides without the need for cofactors and otherwise appear to be simple model systems for presenilin in the gamma-secretase complex. SPP biology, structure, and inhibition will also be discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20482315      PMCID: PMC2997569          DOI: 10.1515/BC.2010.086

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  96 in total

1.  Endoproteolytic processing and stabilization of wild-type and mutant presenilin.

Authors:  T Ratovitski; H H Slunt; G Thinakaran; D L Price; S S Sisodia; D R Borchelt
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

2.  Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue.

Authors:  M B Podlisny; M Citron; P Amarante; R Sherrington; W Xia; J Zhang; T Diehl; G Levesque; P Fraser; C Haass; E H Koo; P Seubert; P St George-Hyslop; D B Teplow; D J Selkoe
Journal:  Neurobiol Dis       Date:  1997       Impact factor: 5.996

3.  Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1.

Authors:  K Duff; C Eckman; C Zehr; X Yu; C M Prada; J Perez-tur; M Hutton; L Buee; Y Harigaya; D Yager; D Morgan; M N Gordon; L Holcomb; L Refolo; B Zenk; J Hardy; S Younkin
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

4.  Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein.

Authors:  B De Strooper; P Saftig; K Craessaerts; H Vanderstichele; G Guhde; W Annaert; K Von Figura; F Van Leuven
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

5.  Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice.

Authors:  M Citron; D Westaway; W Xia; G Carlson; T Diehl; G Levesque; K Johnson-Wood; M Lee; P Seubert; A Davis; D Kholodenko; R Motter; R Sherrington; B Perry; H Yao; R Strome; I Lieberburg; J Rommens; S Kim; D Schenk; P Fraser; P St George Hyslop; D J Selkoe
Journal:  Nat Med       Date:  1997-01       Impact factor: 53.440

6.  Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors.

Authors:  G Thinakaran; C L Harris; T Ratovitski; F Davenport; H H Slunt; D L Price; D R Borchelt; S S Sisodia
Journal:  J Biol Chem       Date:  1997-11-07       Impact factor: 5.157

7.  Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

Authors:  D Scheuner; C Eckman; M Jensen; X Song; M Citron; N Suzuki; T D Bird; J Hardy; M Hutton; W Kukull; E Larson; E Levy-Lahad; M Viitanen; E Peskind; P Poorkaj; G Schellenberg; R Tanzi; W Wasco; L Lannfelt; D Selkoe; S Younkin
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

8.  The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology.

Authors:  C A Lemere; F Lopera; K S Kosik; C L Lendon; J Ossa; T C Saido; H Yamaguchi; A Ruiz; A Martinez; L Madrigal; L Hincapie; J C Arango; D C Anthony; E H Koo; A M Goate; D J Selkoe; J C Arango
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

9.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus.

Authors:  E Levy-Lahad; W Wasco; P Poorkaj; D M Romano; J Oshima; W H Pettingell; C E Yu; P D Jondro; S D Schmidt; K Wang
Journal:  Science       Date:  1995-08-18       Impact factor: 47.728

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more
  23 in total

1.  Residues in conserved loops of intramembrane metalloprotease SpoIVFB interact with residues near the cleavage site in pro-σK.

Authors:  Yang Zhang; Paul M Luethy; Ruanbao Zhou; Lee Kroos
Journal:  J Bacteriol       Date:  2013-08-30       Impact factor: 3.490

Review 2.  Striatal-enriched protein tyrosine phosphatase in Alzheimer's disease.

Authors:  Jian Xu; Pradeep Kurup; Angus C Nairn; Paul J Lombroso
Journal:  Adv Pharmacol       Date:  2012

3.  Second generation γ-secretase modulators exhibit different modulation of Notch β and Aβ production.

Authors:  Johanna Wanngren; Jan Ottervald; Santiago Parpal; Erik Portelius; Kia Strömberg; Tomas Borgegård; Rebecka Klintenberg; Anders Juréus; Jenny Blomqvist; Kaj Blennow; Henrik Zetterberg; Johan Lundkvist; Susanne Rosqvist; Helena Karlström
Journal:  J Biol Chem       Date:  2012-07-31       Impact factor: 5.157

4.  Features of Pro-σK important for cleavage by SpoIVFB, an intramembrane metalloprotease.

Authors:  Ruanbao Zhou; Kangming Chen; Xianling Xiang; Liping Gu; Lee Kroos
Journal:  J Bacteriol       Date:  2013-04-12       Impact factor: 3.490

Review 5.  The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.

Authors:  Steven M Johnson; Stephen Connelly; Colleen Fearns; Evan T Powers; Jeffery W Kelly
Journal:  J Mol Biol       Date:  2012-01-05       Impact factor: 5.469

Review 6.  Protein phosphatases and Alzheimer's disease.

Authors:  Steven P Braithwaite; Jeffry B Stock; Paul J Lombroso; Angus C Nairn
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

7.  Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis.

Authors:  Ivana V Yang; Brent S Pedersen; Einat Rabinovich; Corinne E Hennessy; Elizabeth J Davidson; Elissa Murphy; Brenda Juan Guardela; John R Tedrow; Yingze Zhang; Mandal K Singh; Mick Correll; Marvin I Schwarz; Mark Geraci; Frank C Sciurba; John Quackenbush; Avrum Spira; Naftali Kaminski; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2014-12-01       Impact factor: 21.405

8.  Complex Formed between Intramembrane Metalloprotease SpoIVFB and Its Substrate, Pro-σK.

Authors:  Yang Zhang; Sabyasachi Halder; Richard A Kerr; Daniel Parrell; Brandon Ruotolo; Lee Kroos
Journal:  J Biol Chem       Date:  2016-03-07       Impact factor: 5.157

9.  Discovery of a novel pharmacological and structural class of gamma secretase modulators derived from the extract of Actaea racemosa.

Authors:  Mark A Findeis; Frank Schroeder; Timothy D McKee; Debra Yager; Patrick C Fraering; Steffen P Creaser; Wesley F Austin; Jon Clardy; Rong Wang; Dennis Selkoe; Christopher B Eckman
Journal:  ACS Chem Neurosci       Date:  2012-08-28       Impact factor: 4.418

Review 10.  Targeting protein aggregation for the treatment of degenerative diseases.

Authors:  Yvonne S Eisele; Cecilia Monteiro; Colleen Fearns; Sandra E Encalada; R Luke Wiseman; Evan T Powers; Jeffery W Kelly
Journal:  Nat Rev Drug Discov       Date:  2015-09-04       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.